Surgery Partners, Inc.
SGRY
$21.48
-$0.36-1.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.54% | 14.29% | 14.16% | 7.69% | 4.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.54% | 14.29% | 14.16% | 7.69% | 4.00% |
| Cost of Revenue | 16.43% | 16.64% | 13.52% | 5.62% | 3.63% |
| Gross Profit | 20.66% | 7.06% | 16.29% | 15.90% | 5.05% |
| SG&A Expenses | 72.25% | -20.65% | 29.17% | 3.75% | -27.18% |
| Depreciation & Amortization | 9.00% | 73.70% | 42.62% | 0.00% | 5.07% |
| Other Operating Expenses | -116.28% | -83.33% | -441.67% | -150.00% | 53.26% |
| Total Operating Expenses | 17.29% | 16.99% | 14.72% | 5.01% | 3.08% |
| Operating Income | 18.57% | -0.99% | 10.93% | 30.82% | 7.91% |
| Income Before Tax | 40.80% | -66.77% | -33.27% | 7,275.00% | 58.73% |
| Income Tax Expenses | 1,913.33% | 45.16% | 162.82% | 375.00% | -39.39% |
| Earnings from Continuing Operations | -199.79% | -78.45% | -50.78% | 1,925.00% | 100.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.77% | -10.12% | -13.14% | -40.61% | -2.14% |
| Net Income | -10,750.00% | -546.94% | -182.01% | 50.20% | 95.73% |
| EBIT | 18.57% | -0.99% | 10.93% | 30.82% | 7.91% |
| EBITDA | 16.89% | 15.59% | 17.16% | 20.72% | 7.40% |
| EPS Basic | -10,646.25% | -544.10% | -181.77% | 50.53% | 96.52% |
| Normalized Basic EPS | 9.64% | -1,400.00% | 10.22% | 20.57% | 436.13% |
| EPS Diluted | -10,646.25% | -528.00% | -181.93% | 50.00% | 96.54% |
| Normalized Diluted EPS | 9.64% | -1,400.00% | 8.99% | 20.57% | 436.13% |
| Average Basic Shares Outstanding | 0.35% | 0.34% | 0.33% | 0.61% | 23.44% |
| Average Diluted Shares Outstanding | 0.35% | 0.34% | -0.97% | 0.61% | 23.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |